• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病相关进展率的外周血生物标志物。

Progression Rate Associated Peripheral Blood Biomarkers of Parkinson's Disease.

机构信息

Department of Neurology, Fourth People's Hospital of Jinan, No. 50 Shifan Road, Tianqiao District, Jinan, 250031, Shandong Province, China.

出版信息

J Mol Neurosci. 2018 Jul;65(3):312-318. doi: 10.1007/s12031-018-1102-6. Epub 2018 Jun 23.

DOI:10.1007/s12031-018-1102-6
PMID:29936662
Abstract

Parkinson disease (PD) is one of the most frequent neurodegenerative disorders. The aim of this study was to identify blood biomarkers capable to discriminate PD patients with different progression rates. Differentially expressed genes (DEGs) were acquired by comparing the expression profiles of PD patients with rapid and slow progression rates, using an expression dataset from Gene Expression Omnibus (GEO) under accession code of GSE80599. Altered biological processes and pathways were revealed by functional annotation. Potential biomarkers of PD were identified by protein-protein interaction (PPI) network analysis. Critical transcription factors (TFs) and miRNAs regulating DEGs were predicted by TF analysis and miRNA analysis. A total of 225 DEGs were identified between PD patients with rapid and slow progression profiles. These genes were significantly enriched in biological processes and pathways related to fatty acid metabolism. Among these DEGs, ZFAND4, SRMS, UBL4B, PVALB, DIRAS1, PDP2, LRCH1, and MYL4 were potential progression rate associated biomarkers of PD. Additionally, these DEGs may be regulated by miRNAs of the miR-30 family and TFs STAT1 and GRHL3. Our results may contribute to our understanding of the molecular mechanisms underlying different PD progression profiles.

摘要

帕金森病(PD)是最常见的神经退行性疾病之一。本研究旨在鉴定能够区分具有不同进展速度的 PD 患者的血液生物标志物。通过比较 GEO 数据集(GEO 注册号为 GSE80599)中快速和缓慢进展 PD 患者的表达谱,获得差异表达基因(DEGs)。通过功能注释揭示了改变的生物学过程和途径。通过蛋白质-蛋白质相互作用(PPI)网络分析鉴定 PD 的潜在生物标志物。通过 TF 分析和 miRNA 分析预测调节 DEGs 的关键转录因子(TFs)和 miRNA。在快速和缓慢进展 PD 患者之间的表达谱中鉴定出 225 个 DEGs。这些基因在与脂肪酸代谢相关的生物学过程和途径中显著富集。在这些 DEGs 中,ZFAND4、SRMS、UBL4B、PVALB、DIRAS1、PDP2、LRCH1 和 MYL4 是 PD 进展速度相关的潜在生物标志物。此外,这些 DEGs 可能受 miR-30 家族和 TF STAT1 和 GRHL3 的 miRNA 调节。我们的结果可能有助于我们理解不同 PD 进展谱的分子机制。

相似文献

1
Progression Rate Associated Peripheral Blood Biomarkers of Parkinson's Disease.帕金森病相关进展率的外周血生物标志物。
J Mol Neurosci. 2018 Jul;65(3):312-318. doi: 10.1007/s12031-018-1102-6. Epub 2018 Jun 23.
2
miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.血液中的微小RNA和靶基因作为帕金森病早期诊断的生物标志物。
BMC Syst Biol. 2019 Jan 21;13(1):10. doi: 10.1186/s12918-019-0680-4.
3
Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease.鉴定与帕金森病发展相关的关键基因和 miRNAs。
J Mol Neurosci. 2018 Aug;65(4):527-535. doi: 10.1007/s12031-018-1129-8. Epub 2018 Aug 6.
4
A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.对公共微阵列数据的荟萃分析确定了帕金森病中的生物调节网络。
BMC Med Genomics. 2018 Apr 13;11(1):40. doi: 10.1186/s12920-018-0357-7.
5
Integrated microarray analysis provided a new insight of the pathogenesis of Parkinson's disease.综合微阵列分析为帕金森病的发病机制提供了新的见解。
Neurosci Lett. 2018 Jan 1;662:51-58. doi: 10.1016/j.neulet.2017.09.051. Epub 2017 Sep 28.
6
Integrative Analysis of Gene Expression and Regulatory Network Interaction Data Reveals the Protein Kinase C Family of Serine/Threonine Receptors as a Significant Druggable Target for Parkinson's Disease.基因表达和调控网络互作数据的综合分析揭示蛋白激酶 C 家族丝氨酸/苏氨酸受体是帕金森病的一个重要可药物靶点。
J Mol Neurosci. 2021 Mar;71(3):466-480. doi: 10.1007/s12031-020-01669-7. Epub 2020 Jul 29.
7
An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.帕金森病中 mRNA 和基因表达谱的综合网络分析。
Med Sci Monit. 2020 Mar 25;26:e920846. doi: 10.12659/MSM.920846.
8
Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.基于免疫相关基因的帕金森病诊断与药物预测
J Mol Neurosci. 2022 Sep;72(9):1809-1819. doi: 10.1007/s12031-022-02043-5. Epub 2022 Jun 22.
9
Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.通过 mRNA 和 miRNA 芯片的综合分析探索骨肉瘤的分子机制。
Int J Mol Med. 2018 Jul;42(1):21-30. doi: 10.3892/ijmm.2018.3594. Epub 2018 Mar 27.
10
Identification of Biomolecular Information in Rotenone-Induced Cellular Model of Parkinson's Disease by Public Microarray Data Analysis.通过公共芯片数据分析鉴定鱼藤酮诱导的帕金森病细胞模型中的生物分子信息。
J Comput Biol. 2020 Jun;27(6):888-903. doi: 10.1089/cmb.2019.0151. Epub 2019 Oct 9.

引用本文的文献

1
Integrating Blood Biomarkers and Marine Brown Algae-Derived Inhibitors in Parkinson's Disease: A Multi-scale Approach from Interactomics to Quantum Mechanics.整合血液生物标志物与海洋褐藻衍生抑制剂用于帕金森病:从相互作用组学到量子力学的多尺度方法
Mol Biotechnol. 2024 Sep 3. doi: 10.1007/s12033-024-01262-y.
2
Identifying BMI-associated genes via a genome-wide multi-omics integrative approach using summary data.利用汇总数据通过全基因组多组学综合方法识别 BMI 相关基因。
Hum Mol Genet. 2024 Apr 8;33(8):733-738. doi: 10.1093/hmg/ddad212.
3
Identification of Potential miRNA-mRNA Regulatory Network Contributing to Parkinson's Disease.

本文引用的文献

1
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.MicroRNA-30e 通过靶向 Nlrp3 调节 MPTP 帕金森病模型中的神经炎症。
Hum Cell. 2018 Apr;31(2):106-115. doi: 10.1007/s13577-017-0187-5. Epub 2017 Dec 22.
2
Parkinson disease.帕金森病。
Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13.
3
Selective neuronal vulnerability in Parkinson disease.帕金森病中的选择性神经元易损性。
帕金森病相关潜在miRNA-mRNA调控网络的鉴定
Parkinsons Dis. 2022 Sep 5;2022:2877728. doi: 10.1155/2022/2877728. eCollection 2022.
4
Transcriptome Profiling Reveals Differential Expression of Circadian Behavior Genes in Peripheral Blood of Monozygotic Twins Discordant for Parkinson's Disease.转录组谱分析揭示了帕金森病单卵双胞胎外周血中昼夜行为基因的差异表达。
Cells. 2022 Aug 20;11(16):2599. doi: 10.3390/cells11162599.
5
The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.非受体酪氨酸激酶SRMS通过磷酸化支架蛋白FKBP51来抑制自噬并促进肿瘤生长。
PLoS Biol. 2021 Jun 2;19(6):e3001281. doi: 10.1371/journal.pbio.3001281. eCollection 2021 Jun.
6
LRCH1 deficiency enhances LAT signalosome formation and CD8 T cell responses against tumors and pathogens.LRCH1 缺乏可增强 LAT 信号转导体的形成以及 CD8 T 细胞对肿瘤和病原体的应答。
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19388-19398. doi: 10.1073/pnas.2000970117. Epub 2020 Jul 29.
7
Role of MicroRNAs in Parkinson's Disease.微小 RNA 在帕金森病中的作用。
Int J Mol Sci. 2019 Nov 12;20(22):5649. doi: 10.3390/ijms20225649.
8
Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease.帕金森病中异常表达的长链非编码RNA和基因。
Neuropsychiatr Dis Treat. 2018 Nov 22;14:3219-3229. doi: 10.2147/NDT.S178435. eCollection 2018.
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113. doi: 10.1038/nrn.2016.178.
4
Grainyhead-like 3 (Grhl3) deficiency in brain leads to altered locomotor activity and decreased anxiety-like behaviors in aged mice.脑内 Grainyhead-like 3 (Grhl3) 缺失导致老年小鼠运动活动改变和焦虑样行为减少。
Dev Neurobiol. 2017 Jun;77(6):775-788. doi: 10.1002/dneu.22469. Epub 2017 Feb 3.
5
Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.具有不同病程特征的帕金森病患者外周血中的基因表达差异
PLoS One. 2016 Jun 20;11(6):e0157852. doi: 10.1371/journal.pone.0157852. eCollection 2016.
6
Low BDNF is associated with cognitive impairments in patients with Parkinson's disease.脑源性神经营养因子水平低与帕金森病患者的认知障碍有关。
Parkinsonism Relat Disord. 2016 Aug;29:66-71. doi: 10.1016/j.parkreldis.2016.05.023. Epub 2016 May 24.
7
Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.帕金森病临床诊断的准确性:一项系统评价和荟萃分析。
Neurology. 2016 Feb 9;86(6):566-76. doi: 10.1212/WNL.0000000000002350. Epub 2016 Jan 13.
8
The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?帕金森病线粒体假说:我们现在处于什么位置?
Neuroscientist. 2016 Jun;22(3):266-77. doi: 10.1177/1073858415574600. Epub 2015 Mar 11.
9
CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks.CytoNCA:一种用于蛋白质相互作用网络中心性分析与评估的Cytoscape插件。
Biosystems. 2015 Jan;127:67-72. doi: 10.1016/j.biosystems.2014.11.005. Epub 2014 Nov 15.
10
STRING v10: protein-protein interaction networks, integrated over the tree of life.STRING v10:整合了整个生命之树的蛋白质-蛋白质相互作用网络。
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52. doi: 10.1093/nar/gku1003. Epub 2014 Oct 28.